参考文献/References:
[1]KOCH A E. The pathogenesis of rheumatoid arthritis[J]. American Journal of Orthopedics, 2007, 36(s7):5.
[2]PONCHEL F, MORGAN A W, BINGHAM S J, et al. Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis[J]. Blood, 2002, 100(13):4550.
[3]CHEN R L, TAO Y, HUANG W H. Correlation between CD4+CD28-T cells and lymphocytic apoptosis in rheumatoid arthritis patients[J]. Chinese Journal of Pathophysiology, 2010, 26(9):1824-1827.
[4]VALLEJO A N, SCHIRMER M, WEYAND C M, et al. Clonality and longevity of CD4+CD28 null T cells are associated with defects in apoptotic pathways[J]. Journal of Immunology, 2000, 165(11): 6301.
[5]MCNAMEE K, WILLLIAMS R, SEED M. Animal models of rheumatoid arthritis: how informative are they? [J]. European Journal of Pharmacology, 2015, 759:278-286.
[6]ZHAO M J, WU A M, WANG J, et al. Yiqihuoxuejiedu formula inhibits vascular remodeling by reducing proliferation and secretion of adventitial fibroblast after balloon injury[J]. Evidence-Based Complementray and Alternative Medicine, 2014(2014):1-8.
[7]CHU Y, GUO Y, WALLS A F, et al. The regulatory role of dipeptidyl peptidase 1 on the activation of immune granulocytes[J]. Cell Biology International, 2017, 41(10):1093-1102.
[8]PREETHA A, KUNNUMAKARA A B, CHITRA S, et al. Cancer is a preventable disease that requires major lifestyle changes[J]. Pharmaceutical Research, 2008, 25(9): 2097-2116.
[9]ANAND P, SUNDARAM C, JHURANJ S, et al. Curcumin and cancer: an “old-age” disease with an “age-old” solution[J]. Cancer Letters, 2008, 267(1):133-164.
[10]GAO Y, LI Z, SUN M, et al. Preparation and characterization of intravenously injectable curcumin nanosuspension[J]. Drug Delivery, 2011, 18(2):131.
[11]DAI H S, SHAN T Y, GAO Y, et al. Extractionof curcuminfrom turmeric and study of its methylating[J]. Nat Prod Res Dev, 2008, 20: 254-256.
[12]PATWARDHAN R S, CHECKER R, SHARMA D, et al. Dimethoxycurcumin, a metabolically stable analogue of curcumin, exhibits anti-inflammatory activities in murine and human lymphocytes[J]. Biochemical Pharmacology, 2011, 82(6):642-657.
[13]陆彬. 药物新剂型与新技术[M]. 北京:人民卫生出版社,1998: 230-232.
[14]平其能. 现代药剂学[M]. 北京:中国医药科技出版社,1995: 607-608.
[15]SILVERMAN G J, CARSON D A. Roles of B cells in rheumatoid arthritis[J]. Arthritis Research & Therapy, 2003, 5(s4): 1-6.
[16]FOX D A. The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives[J]. Arthritis & Rheumatology, 2010, 40(4): 598-609.
[17]PAWLOWSKA J, SMOLENSKA Z, WITKOWSKI J, et al. Different pattern of T-cell subpopulations in peripheral blood of patients with rheumatoid arthritis at various stages of disease development[J]. Polskie Archiwum Medycyny Wewne trznej, 2014, 124(1/2): 43.
相似文献/References:
[1]陈鹰娜,李秀文,周晓鹰.孟河古方龙火汤治疗类风湿关节炎的机制[J].常州大学学报(自然科学版),2022,34(06):84.[doi:10.3969/j.issn.2095-0411.2022.06.010]
CHEN Yingna,LI Xiuwen,ZHOU Xiaoying.Mechanism of Classic Menghe Receipt Longhuotang in Treating Rheumatoid Arthritis[J].Journal of Changzhou University(Natural Science Edition),2022,34(04):84.[doi:10.3969/j.issn.2095-0411.2022.06.010]